4Tseng YM,Tsai SM,Chen SY,et al.Roles of the genetic polymorphisms of alcohol-metabolizing enzymes on the immunology in high-risk drinkers[J].Toxicol Sci.2009.111(2):267-276.
5Eriksen J,Olsen PS,Thomsen AC.Gamma-glutamyltranspeptidase,aspartate aminotransferase,and erythrocyte mean corpuscular volume as indicators of alcohol consumption in liver disease[J].Scand J Gastroenterol,1984,19(6):813-819.
6Alatalo P,Koivisto H,Puukka K,et al.Biomarkers of liver status in heavy drinkers,moderate drinkers and abstainers[J].Alcohol,2009,44(2):199-203.
7Gabrielli GB,Faccioli G,Casaril M,et al.Procollagen III peptide and fibronectin in alcohol-related chronic liver disease:correlations with morphological features and biochemical tests[J].Clin Chim Acta,1989,179(3):315-322.
8Allen JP.Use of biomarkers of heavy drinking in health care practice[J].Mil Med,2003,168(5):364-367.
9Alden A,Ohlson S,Pahlsson P,Ryden I.HPLC analysis of carbohydrate deficient transferrin isoforms isolated by the Axis-Shield % CDT method[J].Clin Chim Acta,2005,356(1-2):143-146.
10Helander A,Wielders JP,Te SR,Bergstrom JP.Comparison of HPLC and capillary electrophoresis for confirmatory testing of the alcohol misuse marker carbohydrate-deficient transferrin[J].Clin Chem,2005,51(8):1528-1531.
